Strength
5 mg/1
Manufacturer
AvPAKNDC
50268036115
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075795On Market Since
7/10/2020
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE 5 MG TABLET has been published 298 times since Oct 14, 2020, and over the history we have for it it has risen 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0351 per EA |
|---|---|
| All-time high | $0.0369 (Feb 16, 2022) |
| All-time low | $0.0252 (Nov 20, 2024) |
| 52-week high | $0.0360 |
| 52-week low | $0.0342 |
| Median price | $0.0344 |
| Average price | $0.0339 |
| Largest weekly change | -26.1% (Nov 20, 2024) |
| Weeks tracked | 298 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIPIZIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE 5 MG TABLET, manufactured by AvPAK, is $0.0351 per EA (NDC 50268036115), effective Jun 24, 2026.
How has the price of GLIPIZIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE 5 MG TABLET has risen 5.4%. It has been tracked across 298 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE 5 MG TABLET?
Since Oct 14, 2020, the NADAC for GLIPIZIDE 5 MG TABLET has ranged from a low of $0.0252 (Nov 20, 2024) to a high of $0.0369 (Feb 16, 2022), with a median of $0.0344 per EA.
Are there cheaper alternatives to GLIPIZIDE 5 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as GLIPIZIDE 5 MG TABLET, but none are currently priced below it.
Who manufactures GLIPIZIDE 5 MG TABLET?
GLIPIZIDE 5 MG TABLET (NDC 50268036115) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification